Stay updated on Pyrotinib with Letrozole in HER2+ ER+ MBC Clinical Trial
Sign up to get notified when there's something new on the Pyrotinib with Letrozole in HER2+ ER+ MBC Clinical Trial page.

Latest updates to the Pyrotinib with Letrozole in HER2+ ER+ MBC Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedA system/library version label on the page footer was updated from Revision v3.5.2 to Revision v3.5.3, with no corresponding changes to the clinical trial record history or displayed study details.SummaryDifference0.1%

- Check21 days agoChange DetectedAdded Revision: v3.5.2; Deleted Revision: v3.5.0.SummaryDifference0.1%

- Check28 days agoNo Change Detected
- Check50 days agoChange DetectedAdded revision: v3.5.0 to the history. Deleted revision: v3.4.3 from the history.SummaryDifference0.1%

- Check64 days agoChange DetectedRevision v3.4.3 was added and revision v3.4.2 was removed, reflecting an administrative update to the page history rather than any study content changes.SummaryDifference0.1%

- Check86 days agoChange DetectedThe record history shows a minor revision update from v3.4.1 to v3.4.2; there are no changes to study data, design, or substantive content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check93 days agoChange DetectedThe record history shows a minor version update from v3.4.0 to v3.4.1 with no visible core changes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Pyrotinib with Letrozole in HER2+ ER+ MBC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pyrotinib with Letrozole in HER2+ ER+ MBC Clinical Trial page.